Select one answer only for multiple choices : (1). September 2010…Select one answer only for multiple choices : (1). September 2010…

/in /by

Question Answered step-by-step Select one answer only for multiple choices : (1). September 2010…  Select one answer only for multiple choices :  (1). September 2010 EMA & amp; FDA  (Please choose one acronym/phrase) (a) Drug :5 (Validation) + 90 (review) days(b) Stability studies(c)Confidential agreement _________________________________________________________ (2). Korea (Please choose one acronym/phrase)  (a) Drug :5 (Validation) + 90 (review) days(b) Stability studies(c)Confidential agreement  _________________________________________________________ (3). Holding Time (Please choose one acronym/phrase) (a) Drug :5 (Validation) + 90 (review) days(b) Stability studies(c)Confidential agreement _________________________________________________________ (4). What is the stage of the product lifecycle that demands the integrated attention of clinical operations, regulatory affairs, market access, pharmacovigilance, manufacturing, and other stakeholders? (a) Pilot runs(b) Commercialization(c) Clinical studies(d) Research and Development _________________________________________________________ (5). Which of the following is NOT and IND guidance resource? (a) 21CFR312(b) 21CFR42(c) FDA guidance(d) ICH _________________________________________________________ (6). What FDA regulations governs the manufacture of pharmaceutical products? (a) 21CFR211(b) 21CFR600(c) 21CFR312(d) 21CFR820 _________________________________________________________ (7). Timelines established for authoring a drug product application should include which of the following: (a) meetings with senior management(b) number of studies required(c)  when to request internal resources(d) time it takes to perform a compliance check _________________________________________________________ (8). What was the global generic drug market valued at in 2019? (a) all of these(b) $100 million(c)$278.4 billion(d) $30 trillion _________________________________________________________ (9). What was the first year of a big patient cliff due to a lack of blockbuster drugs? (a) 2019(b) 2005(c)2012(d) 2015 _________________________________________________________  (10). “Patents and restrictions on intellectual property have become more problematic for developing nations in the last decade.”           (a) True           (b) False _________________________________________________________ (11). Module 1. Administrative Information and Prescribing Information. The human study reports and related information should be presented in the order described in the guidance M4E. (CTD Guidance)(a) True (b) False _________________________________________________________ (12). Clinical Investigation of Medical Devices for Human Subjects – Good Clinical Practice (ISO 14155:2011) is an ICH standard. (a) True(b) False ________________________________________________________ (13). MEDDEV (Please choose one acronym/phrase) (a) Guidance document 2.5/10(b) Directive 2001/83/EC ______________________________________________________ (14). Article 48 (Please choose one acronym/phrase) (a) Guidance document 2.5/10(b) Directive 2001/83/EC ________________________________________________________ (15) Fill in the blank: In the CTD you may describe your layout for studies and information in the __________ and _____________.Please provide reference link with this answer.    Health Science Science Nursing NURS MISC Share QuestionEmailCopy link Comments (0)